Biological Seed Treatment Market Report: Trends, Forecast and Competitive Analysis to 2035

Biological Seed Treatment Market

The future of the global biological seed treatment market looks promising with opportunities in the seed enhancement and seed protection markets. The global biological seed treatment market is expected to reach an estimated $5.2 billion by 2035 from $2.7 billion in 2027 with a CAGR of 11.6% from 2027 to 2035. The major drivers for this market are the increasing demand for sustainable crop protection, the rising adoption of eco-friendly seed treatments, and the growing focus on improving agricultural productivity.

• Lucintel forecasts that, within the type category, microbial is expected to witness the highest growth over the forecast period due to increasing adoption of microbial solutions for crop productivity
• Within the function category, seed enhancement is expected to witness higher growth over the forecast period due to rising demand for enhanced seeds
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to advanced agricultural technologies and increasing biostimulant adoption

Emerging Trends in Biological Seed Treatment Market

The biological seed treatment market is moving from specialized to general crop protection use by 2025-2027. Increasing pressure to decrease the use of synthetic inputs, along with onerous residue regulations and the requirement for improved crop yields, will alter procurement practices. Lucintel predicts greater investment in microbials and formulation as well as regional production, but lack of consistency in the field remains a major market challenge.

• Sustainability: In January 2025, the European Commission continued to promote the use of less hazardous biological inputs, while many major seed companies continued to expand their microbial treatment offerings. In the next three to five years, retailer requirements and on-farm sustainability metrics will favor adoption, as long as biologicals can prove effective like conventional crop inputs.
• Microbial Innovation: Market offerings of Bacillus, Trichoderma, rhizobacteria, and other microbial products will further transition to the use of specific strains. Improved packing and coating technologies will allow companies to better protect and enhance the stability of microbial products and facilitate improved and more predictable emergence.
• Digital Agriculture: For the next three to five years, our expectation is that prescription farming technologies will redefine seed treatment recommendations based on soil health and treatment records, motivation maps, and guidance records.
• Regional Supply Chains: Manufacturers are building local fermentation, formulation, and distribution capacity for active ingredients; this was more noticeable after disruptions to agricultural input supplies in 2025. Regional production redefines competition in terms of product freshness and reliability of supply.
• Integrated Crop Protection: Biological seed treatments will be integrated into programs consisting of genetics, chemical seed treatments, and foliar biologicals; 2025 launches of these products consider microbes as complements as opposed to direct competitors. The approach has the potential to address a larger market because the grower's focus is on consistent yield protection rather than single product solutions.

The market is shifting to a new phase where performance spanning crop types and climatic regions as well as storage will influence market dominance. Regulatory approval is not enough for market growth; companies must have better trial data, consistent formulations and integrated solutions which are easily adopted into existing farm machinery. It is anticipated that by 2027, biologicals will start dominating the market more, especially for high value crops, high tech farming. Despite this, market growth will depend on price control.

Recent Developments in the Biological Seed Treatment Market

The biostimulants seed treatment market will be active during the cycle of 2025 to 2027 as microbial products transition from research to commercial products. Market participants are experiencing growth due to a combination of investments, regulatory approvals, and partnerships. Lucintel predicts that the market will become increasingly competitive, particularly as biologicals products gain ground in crop agriculture and precision farming.

• Strategic Partnerships: In January 2025, Syngenta and Bioceres reached an agreement to broaden their biological seed treatment and crop technologies. These partnerships leverage distribution and local microbial expertise to shorten the time to the product via trade channels to growers during the next 3 to 5 years.
• Production Expansion: In March 2025, BASF announced further investment in its agricultural solutions network to support beneficial microorganism-based products. Biological seed treatments for ROW crops will be more reliable due to the expansion of production.
• Technology Launches: In May 2025, Pivot Bio launched further products for commercial agriculture and built on existing field programs covering more than 10 million acres. The company will likely achieve wide adoption of biological seed treatments if they improve microbial stability and productivity.
• Government Approvals: In February 2025, the rules governing microbial biostimulants in the European Union were finalized as part of the fertilizing products regulations. This should incentivize market entrants, even among small and medium sized companies, but will likely continue to be an emerging market due to slow enforcement.
• Impactful Investment: As of October 2025, Bayer targeted biologicals and biological seed treatments within its pipeline and crop science investment focus. Major Agro Chem companies are putting money towards integrating biological solutions with chemical and trait technologies. This will propel the development of product bundling and competitive advantage and increase market pressure on independent players.

The available capital targets microbial and RNA technologies, while regulation currently acts as the main break. In the next 5 years, supplier companies that demonstrate superior performances, registration hedging, product portfolios, and product line fit for existing seed treatments, will dominate the industry. Regional formulation expertise will be necessary even with increased consolidation, as biology is highly heterogenous and will behave distinctly on different farms.

Strategic Growth Opportunities in the Biological Seed Treatment Market

Between 2024 and 2026, biological seed treatment becomes a mainstream crop protection tool. Concerns around synthetic chemistry, resistance, and the need for lower residue farming are driving adoption. Lucintel expects widening adoption due increasing shelf life, field longevity, and precision agriculture integration.

• New Crop Applications: Microbials are moving beyond corn and soybeans to specialty and pulse crops. In February 2025, Novonesis achieved 11% growth in Agriculture for 2024, which supports investment in broader crop applications. Over the next three to five years, crop diversification will increase the volume of treated seeds and reduce reliance on ROW crops.
• Premium Biological Formulations: Heat and drought-protected formulations offer improved strain selection and longer viability with the use of encapsulation. In March 2025, Bayer's annual report shows a €5.9B investment in Crop Science. Where growers focus on reliable seed establishment as opposed to the lowest cost treatments, premium products will command higher margins.
• New Customer Segments: Seed companies, contract growers, and organic producers are becoming direct customers as opposed to solely using distributors. January 2025 census data from the USDA shows over 17,000 certified organic farms. Specialized customers will become a recurring segment for seed treatment biologics.
• Geographic Expansion: Growth opportunities exist for investment in Latin America, India, and Southeast Asia, due to intensive cropping and more strict residue management. In April 2025, Brazil's prediction for its 2024 grain harvest was 300 million tonnes, an all-time high. Localized acreage growth may yield little, if any, profit for suppliers if they do not secure local registrations, formulations, and distributions.
• Digital Manufacturing: Remote automated seed coating and barcode traceability can improve precision in commercial seed coating. In May 2025, the International Seed Federation brought together over 100 seed associations across the globe. The digital systems for quality assurance will lower disputes and enable larger contracts with consistent treatment across global supply chains.

The market for biologic seed treatments will gradually grow if suppliers provide consistent field results, simplify registrations, and fit existing seed supply chains. Revenues will shift to more comprehensive formulations integrated with technical supports and contract-based systems. The greatest success will come to producers who integrate local agronomy and precision farming with high quality manufacturing. The largest inflow of investment will most likely be to producers who have validated seed strains and proven shelf life and grower data.

Biological Seed Treatment Market Drivers and Challenges

The forces shaping growth in biological seed treatments include evolving technologies, economics, sustainability, and regulations. Growth is being driven by demand for microbial products that enhance germination and support crop nutrition and resilience while facilitating a reduction in the use of chemical inputs. There are, however, challenges posed by the need to address inconsistent performance, low farmer awareness, complex regulations, and barriers associated with distribution and marketing. According to Lucintel, innovative biological formulations and sustainable agriculture programs will be the primary drivers for market competitiveness. In the near future, seed treatments are expected to integrate biological approach throughout the globe to support productivity and enhance crop resilience, as well as provide environmental benefits to sustain agriculture.

The following are the key elements that drive the biological seed treatment market:

• Increasing Demand for Sustainable Agriculture: Farmers are focused on using agricultural practices that help in addressing the negative effects of agriculture on the ecosystem. Biological seed treatments contain beneficial organisms as well as biostimulants that can help promote crop nutrients, enhance root growth, and enhance crop establishment. The European Union's Regulation 2021/2115 has begun to influence the Member States' Sustainable Farming Plans, which will begin to be implemented in January 2025. It is expected that sustainability-linked procurement, retailer commitments, and farming preferences, combined with consumer demand, will play a large role in driving biological treatments for agricultural practices in regions with high-value crops and reduced pesticide use over the next 3 to 5 years.
• Microbial Technology: Biological products are becoming more reliable as advances are made in the selection of strains, the stability, and compatibility of formulations with seed coatings. Some of the more recent studies integrate microbes with micronutrients and biostimulants to fight diseases, and modulate germination and stress. With an expected spending of over 30 billion on agronomic research for 2024, more innovations are due to burst into the markets in 2025. For the next 3-5 years, we expect to see added shelf life, consistent on-farm performance, and enhanced compatibility with planting machinery, resulting in a wider use of biological seed treatments of cereals, oilseeds, and pulses beyond the specialty crops.
• Increasing Demand for Crop Productivity and Resilience: The changes in climate along with the degradation of soils and the volatility of input costs give more value to treatments that enable seeds to emerge and grow under stressful conditions of limited water, salt, temperature, and nutrient availability. Biological products support improved root growth and nutrient use efficiency and support the performance of stressed crops. The Food Agriculture Organization (FAO) indicated that in 2023 about 733 million people suffered from hunger, highlighting the importance for increased sustainable production. In the next 3-5 years, growers will be more inclined to adopt resilience focused products for improved early-season growth and to mitigate risks of yield loss due to climate change.
• Regulatory Support and Infrastructure: Governments and agricultural institutions are offering more support for biological inputs through funding for research, low-residue programs, registration pathways, and incentives for sustainable farming. More specific definitions for biostimulants and microbial products will help clarify the position for manufacturers and distributors. In January 2023, the European Union began implementation of its revised Common Agricultural Policy, which continues to provide support for environmental initiatives through 2027. It is anticipated that in the next three to five years, consistent regulations, public demonstration programs, and incentive-based agriculture policies will create a greater level of market confidence and shrink the time and cost for commercialization of biological seed treatments, as well as stimulate capital investments on locally adapted solutions.
• Enhancing Production and Distribution: Technological innovations within fermentation, quality assurance, cold-chain management, and dry formulations technologies have reduced loss within the production process and enhanced consistency of the product. With the growing demand of concentrated, stable powder formulations, and polymer-compatible coatings that remain stable at room temperature within the industry, more manufacturers are able to produce seed treatments with enhanced distribution capabilities. In 2023 the global logistics market exceeded 180 billion parcels. In the next three to five years, increased manufacturing capability and accessibility within agricultural retail will decrease the expense of delivered products, increase market reach, and improve the feasibility of biological seed treatments for small to medium farms.

Challenges specific to this Market include:

• Inconsistent Field Performance: Biological seed treatments may show dissimilar results in the field as a result of soil, temperature, moisture and microbial competition, genetic background of the crop and the way treatments are applied. Due to the gap between lab and field results, farmers do not know how to reliably make a profit. Several products require special storage conditions and precision when they are applied which may also result in a decrease in performance. In 2025, there was a negative impact on agricultural production due to drought in many regions, showing that products must be able to be used in a variety of environmental conditions. Over the next three to five years, inconsistent performance will also negatively impact the pace at which companies can introduce new biological seed treatments if they do not undertake strong field validations, provide more precise application instructions and tailor treatments to different regions.
• Regulatory Complexity and Approval Delays: From a regulatory perspective, a biological seed treatment may be classified as a biopesticide, fertilizer, plant strengthener, or biostimulant based on the product and the claim. Given the fragmented regulations in different countries, there are higher costs and longer timeframes to launch and distribute products internationally. There may be a need to provide evidence of efficacy and safety of the product to the environment and confirmation of microbial identity and process consistency. When compared to many other jurisdictions, the regulatory system in the European Union for microbial plant protection products is more robust and may continue to extend the time for products to be commercialized. In the next three to five years, fragmented regulations will limit smaller companies while larger companies will continue to dominate unless approval systems are based on science and processing time is shortened.
• Limited Awareness, Economics, and Infrastructure: Consistent gaps in awareness and a preference for immediate benefits means many farmers opt for conventional chemical treatments over biological modes of action. Products tend to have high unit values. Inadequate rural storage, support, and distribution further limit the reach of products. Growers prioritized products where the return on investment was evident in 2025. In the next three to five years, a combination of demonstration trials, extension services, financing, and reliable distribution collectively supporting yield protection or input cost savings will dictate adoption.

The biological seed treatment market is expected to grow as interest in microbial and biological solutions for more efficient crop production rises due to the demand for sustainability balanced by climate risk. Additionally, supply chain improvements through the manufacturing and delivery of more reliable and affordable product offerings as well as formal regulation may provide further support to this industry. There are many significant barriers that remain including field results that are not consistent, complicated approvals, limited awareness, and distribution. Strong scientific validation for biological seed treatments that is contextual and intersectional and supply assurances may enable the market leaders to capture the most value. Overall, adoption is anticipated to grow though it will still be largely dependent on measurable return on investments and predictable performance of the products.

List of Biological Seed Treatment Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biological seed treatment market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biological seed treatment market companies profiled in this report include-

• BASF SE
• Bayer AG
• Novozymes A/S
• Syngenta Group
• Corteva Agriscience
• Rhizobacter
• ValentBioSciences
• Verdesian Lifescience
• Plant Health Care
• Bioworks

Biological Seed Treatment Market by Segment

The study includes a forecast for the global biological seed treatment market by type, crop type, function, and region.

Biological Seed Treatment Market by Type [Value ($B) from 2019 to 2035]:

• Microbials
• Botanical
• Others

Biological Seed Treatment Market by Crop Type [Value ($B) from 2019 to 2035]:

• Corn
• Wheat
• Soybean
• Cotton
• Sunflower
• Vegetable Crops
• Others

Biological Seed Treatment Market by Function [Value ($B) from 2019 to 2035]:

• Seed Enhancement
• Seed Protection

Biological Seed Treatment Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Biological Seed Treatment Market

The biological seed treatment market is transitioning from a niche use of biologicals to integrated, registration compatible crop inputs. Companies are focusing on microbial effectiveness and farmer-friendly formulations and local production from 2025 to 2027. According to Lucintel's market report, these shifts are influencing how companies compete, but will most likely continue to maintain existing seed treatment portfolios.

• United States: Regulatory progress and investment in manufacturing: The Environmental Protection Agency provided 23 new biopesticide active ingredients registrations in 2025, facilitating the expansion of microbial seed treatment sales, while major crop input companies continued expanding their biological product pipelines and partnerships. This progress should shorten the time it takes to bring biological products to market and build greater supply in the United States over the next three to five years.
• China: Expansion of domestic biological-input capacity and policy support: The 2025 pesticide-management policy framework of the Ministry of Agriculture and Rural Affairs promoted the development of microbial pesticides and reduced-chemical agricultural inputs, while Chinese manufacturing companies initiated expansions of their fermentation and formulation facilities. The direction of this policy will cause an improvement in domestic availability of biological technologies of the U.S. market, while reducing the market's reliance on imported technologies.
• Germany: Regional manufacturing and biological solutions: BASF continued its investment in biological solutions while maintaining the investment in chemical crop protection. The microbial products registered in the European Union in January 2025 continue to support the development of products that meet the increasing registration requirements. Germany will likely continue to be an important manufacturing, research, and regulatory location for products sold across the European Union.
• India: Continued advancement of the National Mission on Natural Farming, in its second year of funding, resulted in the further development of biofertilizers and biopesticides. Growing demand from government-sponsored programs will strengthen the domestic manufacturing of seed-applied microbial products.
• Japan: The ongoing implementation of the MIDORI strategy in the Ministry of Agriculture will help support a 50% decrease in pesticide use by 2050. As a result, Japanese companies will help develop biostimulants and microbial coatings. Policy fosters advancements in biological seed treatments through field validation, and partnership developments with registrations.

Features of the Global Biological Seed Treatment Market

• Market Size Estimates: biological seed treatment market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: biological seed treatment market size by type, crop type, function, and region in terms of value ($B).
• Regional Analysis: biological seed treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, crop types, functions, and regions for the biological seed treatment market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biological seed treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biological seed treatment market by type (microbials, botanical, and others), crop type (corn, wheat, soybean, cotton, sunflower, vegetable crops, and others), function (seed enhancement and seed protection), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?